✦ LIBER ✦

Cost-Effectiveness Analysis of Biological Disease-Modifying Antirheumatic Drugs in the Treatment of Russian Patients with Rheumatoid Arthritis Who Failed Previous Anti-Tnf-Alfa Therapy

✍ Scribed by Ryazhenov, V.V.; Emchenko, I.V.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UK cost-utility analysis of rituximab in

✍ Kielhorn, Adrian; Porter, Duncan; Diamantopoulos, Alexander; Lewis, Gavin 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 147 KB

Indirect comparisons of the efficacy of

✍ Salliot, C.; Finckh, A.; Katchamart, W.; Lu, Y.; Sun, Y.; Bombardier, C.; Keysto 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 299 KB

PMS33 COST EFFECTIVENESS OF ABATACEPT IN

✍ F. Becerra Rojas; C. Benites Chacaltana; E.C. Aiello; C. Zingoni; G. Bergman; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB